Search | TVST | ARVO Journals

Showing 1 – 20 of 48

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Interpericyte tunneling nanotubes regrow after transient ischemia

Jesse Wilson Gardner-Russell; Hojin Chang; Verena C Wimmer; Kelly Rogers; Bang V Bui; Peter van Wijngaarden; Keith R Martin; Luis Alarcon-Martinez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):273.

Retina July 2023

Systematic Underestimation of Visual Sensitivity Loss on Microperimetry: Implications for Testing Protocols in Clinical Trials

PDF

Zhichao Wu; Xavier Hadoux; Maxime Jannaud; Keith R. Martin; Peter van Wijngaarden; Robyn H. Guymer
TAGS: eye, glaucoma, stairs, perimetry, retinal imaging, nigeria, age-related macular degeneration, nonexudative
Trans. Vis. Sci. Tech.. 2023; 12(7):11. https://doi.org/10.1167/tvst.12.7.11

ARVO Annual Meeting Abstract June 2022

Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss in a Clinical Population

Aidan Bernard Jackson; Michael A Coote; Keith R Martin; Zhichao Wu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1252 – A0392.

ARVO Annual Meeting Abstract June 2021

Neuronal Activity-Dependent Myelin Plasticity during Adulthood

Wanyi Jia; Tasneem Khatib; Keith R Martin; Ragnhildur Thora Karadottir

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1396.

ARVO Annual Meeting Abstract June 2020

Neutralising antibody responses to intravitreally delivered AAV2 and exosome-associated AAV2 vectors are associated with a failure of repeated gene transfer following vector readministration in the ipsilateral eye

Michael Whitehead; Andrew Osborne; Peter Widdowson; Patrick Yu-Wai-Man; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2441.

ARVO Annual Meeting Abstract June 2020

Improvement in inner retinal function in glaucoma in response to nicotinamide (Vitamin B 3 ) supplementation: a crossover randomized clinical trial

Flora Hui; Jessica Tang; Pete Williams; Myra McGuinness; Xavier Hadoux; Robert James Casson; Michael Coote; Ian Trounce; Keith R Martin; Peter van Wijngaarden; Jonathan Guy Crowston

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3493.

Anatomy and Pathology/Oncology November 2019

Expression of Developmentally Important Axon Guidance Cues in the Adult Optic Chiasm

PDF

Raquel Conceição; Rachel S. Evans; Craig S. Pearson; Barbara Hänzi; Andrew Osborne; Sarita S. Deshpande; Keith R. Martin; Amanda C. Barber
TAGS: adult, axon guidance, cues, optic chiasms, mice, brain, embryo
Invest. Ophthalmol. Vis. Sci.. 2019; 60(14):4727-4739. https://doi.org/10.1167/iovs.19-26732

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Non-invasive in vivo imaging and quantification of human aqueous outflow

Tasneem Khatib; Paul AR Meyer; Jed Lusthaus; Ilya Manyakin; Yusuf Mushtaq; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5606.

ARVO Annual Meeting Abstract July 2018

Comparison of Perimetry for Glaucoma Using Standard Size iPad and Large Screen iPad Pro with Humphrey Field Analyzer.

Yu Xiang George Kong; Lukas Sahhar; Keith R Martin; Mingguang He; Jonathan G Crowston; Algis J Vingrys

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5126.

ARVO Annual Meeting Abstract July 2018

Pointwise variability of a tablet perimetry application.

Algis J Vingrys; Selwyn M Prea; Aditi Mehta; Mingguang He; Jonathan G Crowston; Viney Gupta; Keith R Martin; Yu Xiang George Kong

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5127.

ARVO Annual Meeting Abstract July 2018

QTA020V, a novel rAAV2 vector, reduces retinal ganglion cell body and axon loss in rats with laser-induced intraocular pressure elevation

Peter S Widdowson; Andrew Osborne; Tasneem Khatib; Katie Hall; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6132.

ARVO Annual Meeting Abstract July 2018

Sustained up-regulation of neuroprotective intracellular signalling pathways in retinal ganglion cells following intravitreal injection of QTA020V, a novel rAAV2 vector

Andrew Osborne; Lalana Songra; Peter S Widdowson; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6133.

ARVO Annual Meeting Abstract July 2018

Tau dysfunction in glaucoma: modulation of optic nerve axonal transport via gene therapy

Tasneem Khatib; Andrew Osborne; Peter S Widdowson; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3716.

ARVO Annual Meeting Abstract July 2018

Arylsulfatase B modifies chondroitin sulfation and enhances retinal ganglion cell axon regeneration

Craig Pearson; Keith R Martin; Herbert M Geller

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3723.

ARVO Annual Meeting Abstract June 2017

Needling procedures following trabeculectomy – predictive factors and a retrospective study of outcomes

Toby Al-Mugheiry; Jonathan Than; Jesse Gale; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4942.

ARVO Annual Meeting Abstract June 2017

Modifying chondroitin sulfate proteoglycans enhances retinal ganglion cell axon regeneration in the mouse optic nerve

Craig Pearson; Herbert M. Geller; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1739.

ARVO Annual Meeting Abstract June 2017

Transgene expression, processing and activity following intravitreal Injection of QTA020V, a novel rAAV2 vector for retinal ganglion cell neuroprotection

Andrew Osborne; Peter S Widdowson; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2568.

ARVO Annual Meeting Abstract June 2017

Design and characterisation of an AAV2 vector aiming to achieve long term modulation of BDNF signalling as a treatment for glaucoma

Peter S Widdowson; Andrew Osborne; Alessia Tassoni; Keith R Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2569.

ARVO Annual Meeting Abstract June 2017

Longitudinal comparison of visual field outcomes obtained by a tablet perimeter and those returned by Humphrey Field Analyzer

Yu Xiang George Kong; Mingguang He; Jonathan Crowston; Keith R Martin; Algis J Vingrys

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2866.

ARVO Annual Meeting Abstract June 2017

QTA020V, a novel rAAV2 vector, delays retinal ganglion cell loss following optic nerve crush in the mouse

Keith R Martin; Andrew Osborne; Tasneem Khatib; Amanda Barber; George Kong; Peter S Widdowson

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2954.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Interpericyte tunneling nanotubes regrow after transient ischemia

Systematic Underestimation of Visual Sensitivity Loss on Microperimetry: Implications for Testing Protocols in Clinical Trials

Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss in a Clinical Population

Neuronal Activity-Dependent Myelin Plasticity during Adulthood

Neutralising antibody responses to intravitreally delivered AAV2 and exosome-associated AAV2 vectors are associated with a failure of repeated gene transfer following vector readministration in the ipsilateral eye

Improvement in inner retinal function in glaucoma in response to nicotinamide (Vitamin B 3 ) supplementation: a crossover randomized clinical trial

Expression of Developmentally Important Axon Guidance Cues in the Adult Optic Chiasm

Non-invasive in vivo imaging and quantification of human aqueous outflow

Comparison of Perimetry for Glaucoma Using Standard Size iPad and Large Screen iPad Pro with Humphrey Field Analyzer.

Pointwise variability of a tablet perimetry application.

QTA020V, a novel rAAV2 vector, reduces retinal ganglion cell body and axon loss in rats with laser-induced intraocular pressure elevation

Sustained up-regulation of neuroprotective intracellular signalling pathways in retinal ganglion cells following intravitreal injection of QTA020V, a novel rAAV2 vector

Tau dysfunction in glaucoma: modulation of optic nerve axonal transport via gene therapy

Arylsulfatase B modifies chondroitin sulfation and enhances retinal ganglion cell axon regeneration

Needling procedures following trabeculectomy – predictive factors and a retrospective study of outcomes

Modifying chondroitin sulfate proteoglycans enhances retinal ganglion cell axon regeneration in the mouse optic nerve

Transgene expression, processing and activity following intravitreal Injection of QTA020V, a novel rAAV2 vector for retinal ganglion cell neuroprotection

Design and characterisation of an AAV2 vector aiming to achieve long term modulation of BDNF signalling as a treatment for glaucoma

Longitudinal comparison of visual field outcomes obtained by a tablet perimeter and those returned by Humphrey Field Analyzer

QTA020V, a novel rAAV2 vector, delays retinal ganglion cell loss following optic nerve crush in the mouse

To View More...

You must be signed into an individual account to use this feature.